LUCA JUUHL: Open Payments
NPI 1841901261 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,956 in 79 payments from 21 companies in 2025. Trend: 2023 $3,040 · 2024 $2,513 · 2025 $1,956
Food & beverage: $1,956
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $267 |
| Vanda Pharmaceuticals Inc. | 7 | $252 |
| ABBVIE INC. | 10 | $227 |
| E.R. Squibb & Sons, L.L.C. | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Tris Pharma Inc | 5 | $106 |
| Alkermes, Inc. | 5 | $105 |
| Neurocrine BioSciences, Inc. | 4 | $103 |
| Lundbeck LLC | 4 | $96 |
| Almatica Pharma LLC | 3 | $81 |
Products named: Auvelity, FANAPT, VRAYLAR, REXULTI, COBENFY, Dyanavel XR, ARISTADA, INGREZZA.
Industry payments across IL — which companies pay providers there.
